Name: Name:2-(1,3-Dioxo-1H-benzo[de]isoquinolin-2(3H)-yl)acetic acid
Brand: AABLOCKS
SKU: AA00D9U0
Rating: 90 (10 reviews)

Catalog No.: AA00D9U0

51411-04-2 | 2-(1,3-Dioxo-1H-benzo[de]isoquinolin-2(3H)-yl)acetic acid

Pack Size： 1mg

Purity： 98+%

in stock

$26.00 $19.00

Pack Size： 5mg

Purity： 98+%

in stock

$66.00 $46.00

Pack Size： 10mg

Purity： 98+%

in stock

$85.00 $60.00

Pack Size： 50mg

Purity： 98+%

in stock

$144.00 $101.00

Quantity

- +

Add to Card

Order Now

bulk Quotation Request

Technical Information

Catalog Number: AA00D9U0

Chemical Name: 2-(1,3-Dioxo-1H-benzo[de]isoquinolin-2(3H)-yl)acetic acid

CAS Number: 51411-04-2

Molecular Formula: C14H9NO4

Molecular Weight: 255.2256

MDL Number: MFCD00181399

SMILES: OC(=O)Cn1c(=O)c2cccc3c2c(c1=O)ccc3

Properties

Form: Solid

MP: 266-267℃

Storage: Keep in dry area;2-8℃;

Complexity: 403

Covalently-Bonded Unit Count: 1

Defined Atom Stereocenter Count: 0

Defined Bond Stereocenter Count: 0

Formal Charge: 0

Heavy Atom Count: 19

Hydrogen Bond Acceptor Count: 4

Hydrogen Bond Donor Count: 1

Isotope Atom Count: 0

Rotatable Bond Count: 2

Undefined Atom Stereocenter Count: 0

Undefined Bond Stereocenter Count: 0

XLogP3: 1.7

Downstream Synthesis Route

353262-66-5

51411-04-2

[1]JournaloftheChemicalSociety,1931,p.871,872

67-56-1

51411-04-2

135980-44-8

[1]BulletinoftheChemicalSocietyofJapan,2011,vol.84,p.520-525

[2]HelveticaChimicaActa,1938,vol.21,p.1466,1479,1480

51411-04-2

592515-22-5

[1]TetrahedronAsymmetry,2003,vol.14,p.1355-1361

[2]JournaloftheChemicalSociety,1931,p.871,872

81-84-5

56-40-6

51411-04-2

[1]EuropeanJournalofMedicinalChemistry,1998,vol.33,p.15-22

[2]JournalofOrganometallicChemistry,2013,vol.729,p.28-39

[3]CrystalGrowthandDesign,2011,vol.11,p.4068-4079

[4]CrystEngComm,2013,vol.15,p.10470-10480

[5]SyntheticCommunications,2006,vol.36,p.1933-1940

[6]Chemistry-AEuropeanJournal,2018,vol.24,p.18718-18734

[7]JournalofMaterialsChemistryC,2015,vol.3,p.1799-1806

[8]TetrahedronAsymmetry,2003,vol.14,p.1355-1361

[9]Patent:US2018/52170,2018,A1.Locationinpatent:Paragraph0057-0061

[10]NewJournalofChemistry,2018,vol.42,p.16167-16173

[11]OrganicandBiomolecularChemistry,2012,vol.10,p.126-133

[12]BulletinoftheChemicalSocietyofJapan,2011,vol.84,p.520-525

[13]JournalofPhysicalChemistryB,2003,vol.107,p.12838-12841

[14]Patent:CN103948595,2017,B.Locationinpatent:Paragraph0045;0046;0047;0048

[15]MedicinalChemistryResearch,2017,vol.26,p.2235-2242

[16]BioorganicChemistry,2019,vol.92

98-10-2

51411-04-2

N-2-(1,3-Dioxo-1H,3H-benzodeisoquinolin-2-yl)-acetyl-benzenesulfonamide

[1]EuropeanJournalofMedicinalChemistry,1998,vol.33,p.15-22

Literature fold

Title: Copper(II) carboxylate dimers prepared from ligands designed to form a robust π···π stacking synthon: supramolecular structures and molecular properties.

Journal: Inorganic chemistry20120116

Title: The Prostaglandin F Synthase Activity of the Human Aldose Reductase AKR1B1 Brings New Lenses to Look at Pathologic Conditions.

Journal: Frontiers in pharmacology20120101

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters20101101

Title: Diabetic cataract-pathogenesis, epidemiology and treatment.

Journal: Journal of ophthalmology20100101

Title: Advances in pharmacological strategies for the prevention of cataract development.

Journal: Indian journal of ophthalmology20090101

Title: Mechanism of high glucose induced angiotensin II production in rat vascular smooth muscle cells.

Journal: Circulation research20070831

Title: Upregulation of aldose reductase by homocysteine in type II alveolar epithelial cells.

Journal: Biochemical and biophysical research communications20051202

Title: Proteomic analysis of oxidative stress-resistant cells: a specific role for aldose reductase overexpression in cytoprotection.

Journal: Molecular & cellular proteomics : MCP20040201

Title: Neonicotinoid insecticides: reduction and cleavage of imidacloprid nitroimine substituent by liver microsomal and cytosolic enzymes.

Journal: Chemical research in toxicology20020901

Title: Impairment of type III group B Streptococcus-stimulated superoxide production and opsonophagocytosis by neutrophils in diabetes.

Journal: Molecular genetics and metabolism20010701

Title: Aldose reductase inhibitors: a potential new class of agents for the pharmacological control of certain diabetic complications.

Journal: Journal of medicinal chemistry19850701

Title: N-[5-(trifluoromethyl)-6-methoxy-1-naphthalenyl]thioxomethyl]- N-methylglycine (Tolrestat), a potent, orally active aldose reductase inhibitor.

Journal: Journal of medicinal chemistry19840301